68166 stocks real-time data.
All stocks today

Stock quotes

Stock market live

Historical stock prices

Stocks market capitalization

Dividend stocks

Stock earnings

Stock revenue

Stock ratings. Where to invest?

Abbott Laboratories market cap

Abbott Laboratories volume of trade today and historical data of Abbott Laboratories capitalization since start date of trade of ABT stocks.
Add to widgets
Added to widgets

Abbott Laboratories capitalization

Today's market capitalization for Abbott Laboratories is 131 900 375 040 US dollar.
-263 454 720 $ (-0.20%)
change of capitalization since yesterday

Abbott Laboratories volume of trade

Today's Abbott Laboratories volume of trade is 3 387 977 US dollar.
-4 682 558 $ (-58.02%)
change of volume of trade since yesterday
Show:
to

Abbott Laboratories market cap chart

Week Month 3 months Year 3 years

Abbott Laboratories capitalization history

Date Capitalization
Market capitalization (market cap) is the market value of a publicly traded company's outstanding shares. Market capitalization is equal to the share price multiplied by the number of shares outstanding.
19/02/2019 131 900 375 040 $
15/02/2019 132 163 829 760 $
14/02/2019 130 237 833 216 $
13/02/2019 130 361 663 488 $
12/02/2019 131 830 120 448 $
11/02/2019 129 160 511 488 $
08/02/2019 128 422 854 656 $

Abbott Laboratories volume chart

Week Month 3 months Year 3 years

Abbott Laboratories volume history data

Date Volume (24h)
Volume of trade of Abbott Laboratories - total sum in US dollars for all deals with ABT stocks bought and sold during selected date.
19/02/2019 3 387 977 $
15/02/2019 8 070 535 $
14/02/2019 3 138 323 $
13/02/2019 2 151 552 $
12/02/2019 7 039 987 $
11/02/2019 4 782 802 $
08/02/2019 1 212 736 $

Abbott Laboratories capitalization is 131 900 375 040 $ now. Market capitalization of Abbott Laboratories changed by -0.199% since yesterday. Today's volume of trade of ABT stocks was 3 387 977 $. ABT volume of trade amount changed to -58.0204% since yesterday.

Abbott Laboratories stocks data

Abbott Laboratories financials